Ascelus Research Projects

Prostate cancer (PC) is the most common male cancer worldwide. Each year 10,000 UK men are diagnosed with advanced disease and incidence has increased by 41% since the early 1990s.

15 million people in England and 133 million people in the US are living with a long-term condition (including cancer). Healthcare systems are under huge capacity and financial strain because demand for long-term condition management continues to grow and is outpacing supply.

Immunotherapy fights cancer but can cause side effects, both early and late. We’re partnering with academics and clinicians to research safer ways to manage these, improving patient lives and easing the burden on hospitals.